Effects of DDT and triclosan on tumor‐cell binding capacity and cell‐surface protein expression of human natural killer cells
Year: 2012
Type: article
Abstract: 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) and triclosan (TCS) are organochlorine (OC) compounds that contaminate the environment, are found in human blood and have been shown to decrease the tumor-cell killing (lytic) function of human natural killer (NK) cells. NK cells defend against tumor cells and virally infected cells. They bind to these targets, utilizing a variety of cell surface proteins. The present study examined concentrations of DDT and TCS that decrease lytic function for alteration of NK binding to tumor targets. Levels of either compound that caused loss of binding function were then examined for effects on expression of cell-surface proteins needed for binding. NK cells exposed to 2.5 μM DDT for 24 h (which caused a greater than 55% loss of lytic function) showed a decrease in NK binding function of about 22%, and a decrease in CD16 cell-surface protein of 20%. NK cells exposed to 5 μM TCS for 24 h showed a decrease in ability to bind tumor cells of 37% and a decrease in expression of CD56 of about 34%. This same treatment caused a decrease in lytic function of greater than 87%. These results indicated that only a portion of the loss of NK lytic function seen with exposures to these compounds could be accounted for by loss of binding function. They also showed that loss of binding function is accompanied by a loss of cell-surface proteins important in binding function.
Source: Journal of Applied Toxicology
DOI: 10.1002/jat.2767
Authors: Tasia Hurd‐Brown, Felicia Udoji, Tamara Martin, Margaret M. Whalen
Institution: Tennessee State University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Awards: Enhancing Biomedical Research at Tennessee State University, G639748421, MARC Undergraduate Student Training in Academic Research at Tennessee State University, 1/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities, (3 of 3) MMC, VICC & TSU: Partners in Eliminating Cancer Disparities
OpenAlex ID: W1925870851
